The store will not work correctly when cookies are disabled.
2-Amino-4-((1R,4R)-4-hydroxycyclohexylamino)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide
ID: ALA4092101
PubChem CID: 137655801
Max Phase: Preclinical
Molecular Formula: C13H18N6O2
Molecular Weight: 290.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1c[nH]c2nc(N)nc(N[C@H]3CC[C@H](O)CC3)c12
Standard InChI: InChI=1S/C13H18N6O2/c14-10(21)8-5-16-11-9(8)12(19-13(15)18-11)17-6-1-3-7(20)4-2-6/h5-7,20H,1-4H2,(H2,14,21)(H4,15,16,17,18,19)/t6-,7-
Standard InChI Key: MGGSRUMGOBISBK-LJGSYFOKSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
4.6237 -11.2371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6225 -12.0660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3387 -12.4796 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3368 -10.8236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0535 -11.2335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0584 -12.0614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8473 -12.3126 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3301 -11.6400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8395 -10.9730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3315 -10.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9107 -12.4784 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6177 -9.5951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6146 -8.7765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9049 -8.3716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1950 -8.7839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1992 -9.6054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9135 -10.0146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0902 -10.1855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8976 -10.0090 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5336 -9.5746 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4776 -8.3734 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
2 11 1 0
12 10 1 1
12 13 1 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
9 18 1 0
18 19 1 0
18 20 2 0
15 21 1 6
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 290.33 | Molecular Weight (Monoisotopic): 290.1491 | AlogP: 0.35 | #Rotatable Bonds: 3 |
Polar Surface Area: 142.94 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 5 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.62 | CX Basic pKa: 7.70 | CX LogP: -0.30 | CX LogD: -0.93 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.55 | Np Likeness Score: -0.48 |
References
1. Anthony NG, Baiget J, Berretta G, Boyd M, Breen D, Edwards J, Gamble C, Gray AI, Harvey AL, Hatziieremia S, Ho KH, Huggan JK, Lang S, Llona-Minguez S, Luo JL, McIntosh K, Paul A, Plevin RJ, Robertson MN, Scott R, Suckling CJ, Sutcliffe OB, Young LC, Mackay SP.. (2017) Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers., 60 (16): [PMID:28737909] [10.1021/acs.jmedchem.7b00484] |